However, we found that SCGB1D2 protein expression is inversely correlated with serum S100B levels at the primary diagnosis, supporting the protective role of SCGB1D2. Interestingly, we found that the presence of KRT9 and DCD expression were more likely to be found in non-SSM subtypes. This evidence concerns the gene S100B and superficial spreading melanoma.